HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Simona Pisanti Selected Research

2-methylarachidonyl-2'-fluoroethylamide

12/2008The anandamide analog, Met-F-AEA, controls human breast cancer cell migration via the RHOA/RHO kinase signaling pathway.
5/2007Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacy.
2/2006Anandamide inhibits adhesion and migration of breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Simona Pisanti Research Topics

Disease

29Neoplasms (Cancer)
07/2020 - 02/2006
9Breast Neoplasms (Breast Cancer)
11/2012 - 11/2005
6Colorectal Neoplasms (Colorectal Cancer)
01/2016 - 07/2008
5Neoplasm Metastasis (Metastasis)
07/2020 - 02/2006
5Glioma (Gliomas)
01/2018 - 06/2015
4Obesity
01/2010 - 06/2007
3Brain Neoplasms (Brain Tumor)
10/2017 - 06/2015
3Inflammation (Inflammations)
10/2017 - 02/2009
3Multiple Sclerosis
06/2015 - 02/2006
3Colonic Neoplasms (Colon Cancer)
01/2012 - 09/2009
2Melanoma (Melanoma, Malignant)
01/2018 - 12/2014
2Substance-Related Disorders (Drug Abuse)
01/2010 - 06/2007
2Necrosis
09/2009 - 10/2006
1Anemia
01/2021
1Wounds and Injuries (Trauma)
05/2020
1COVID-19
01/2020
1Disease Susceptibility (Diathesis)
01/2020
1Glioblastoma (Glioblastoma Multiforme)
10/2017
1Hyperglycemia
10/2017
1Prostatic Neoplasms (Prostate Cancer)
06/2015
1Dermatitis
11/2014
1Nervous System Diseases (Neurological Disorders)
12/2013
1Coronary Disease (Coronary Heart Disease)
01/2012
1Carcinoma (Carcinomatosis)
02/2011
1Aberrant Crypt Foci
09/2009
1Carcinogenesis
09/2009
1Pain (Aches)
08/2009
1Anorexia
08/2009
1Weight Loss (Weight Reduction)
08/2009
1Nausea
08/2009

Drug/Important Bio-Agent (IBA)

11EndocannabinoidsIBA
05/2013 - 02/2006
9CB1 Cannabinoid Receptor (CB1 Receptor)IBA
06/2015 - 11/2005
7Cannabinoid Receptors (Cannabinoid Receptor)IBA
05/2013 - 11/2005
7anandamide (arachidonylethanolamide)IBA
11/2012 - 11/2005
6Mevalonic Acid (Mevalonate)IBA
01/2018 - 12/2013
6RimonabantIBA
06/2015 - 02/2006
6CannabinoidsIBA
12/2013 - 05/2006
5LipidsIBA
10/2017 - 11/2005
4EnzymesIBA
10/2017 - 02/2011
3Biological ProductsIBA
01/2021 - 11/2014
3Adenosine (Adenocard)FDA LinkGeneric
01/2018 - 11/2014
3Terpenes (Terpenoids)IBA
01/2018 - 01/2017
32-methylarachidonyl-2'-fluoroethylamideIBA
12/2008 - 02/2006
2LigandsIBA
01/2018 - 01/2012
2Proteins (Proteins, Gene)FDA Link
10/2017 - 11/2012
2CholesterolIBA
10/2017 - 01/2012
2CannabidiolIBA
07/2017 - 09/2006
2Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2016 - 01/2010
2CB2 Cannabinoid ReceptorIBA
06/2015 - 12/2013
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2014 - 01/2012
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
05/2013 - 11/2005
22-methyl-2'-F-anandamideIBA
06/2010 - 05/2007
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2020
1AntioxidantsIBA
05/2020
1A-factor (Streptomyces)IBA
01/2020
1HLA-A Antigens (HLA-A)IBA
01/2020
1Small Interfering RNA (siRNA)IBA
01/2018
1Cytotoxins (Cytolysins)IBA
01/2018
1pifithrinIBA
01/2018
1GeranyltranstransferaseIBA
10/2017
1Messenger RNA (mRNA)IBA
10/2017
1AdenineFDA LinkGeneric
07/2017
1farnesyl pyrophosphate (farnesyl diphosphate)IBA
07/2017
1Bcl-2-Like Protein 11IBA
01/2017
1Growth Factor ReceptorsIBA
01/2017
1TubulinIBA
01/2016
1Fluorouracil (Carac)FDA LinkGeneric
01/2016
1micaIBA
06/2015
1Interleukin-6 (Interleukin 6)IBA
12/2014
1Croton OilIBA
11/2014
1NucleosidesIBA
12/2013
1Pharmaceutical PreparationsIBA
12/2013
1CarcinogensIBA
05/2013
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
05/2013
1ElementsIBA
11/2012
1CateninsIBA
11/2012
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2012
1TCF Transcription FactorsIBA
11/2012
1SteroidsIBA
01/2012
1Hormones (Hormone)IBA
01/2012
1Olive OilIBA
02/2011
1Fatty Acids (Saturated Fatty Acids)IBA
02/2011
1Fatty Acid Synthases (Fatty Acid Synthase)IBA
02/2011
1PolyphenolsIBA
02/2011
13-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA
06/2010
1Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA
06/2010
1Oxidoreductases (Dehydrogenase)IBA
06/2010
1Cannabinoid Receptor AntagonistsIBA
01/2010
1AzoxymethaneIBA
09/2009
1Cannabinoid Receptor AgonistsIBA
02/2009
1rho-Associated KinasesIBA
12/2008
1Lovastatin (Mevacor)FDA LinkGeneric
12/2008
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
06/2008
1Cyclic AMP (AMP, Cyclic)IBA
06/2008
1Adenylyl Cyclases (Adenylyl Cyclase)IBA
06/2008
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
06/2008
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
06/2008
1Anti-Obesity Agents (Antiobesity Drugs)IBA
06/2007

Therapy/Procedure

7Therapeutics
07/2020 - 05/2006
3Drug Therapy (Chemotherapy)
01/2018 - 09/2006